Challenging Drug Regulation: The Call for FDA Reform

This chapter explores Jim O'Neill's controversial views on reforming the FDA and the drug approval process. It features insights from various stakeholders regarding the implications of these reforms on drug accessibility and safety.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app